Ping-Chang Kuo Selected Research

Brain Ischemia (Cerebral Ischemia)

12/2017	A Combination of Three Repurposed Drugs Administered at Reperfusion as a Promising Therapy for Postischemic Brain Injury.
5/2017	3H-1,2-Dithiole-3-thione as a novel therapeutic agent for the treatment of ischemic stroke through Nrf2 defense pathway.
1/2016	Interferon-β Modulates Inflammatory Response in Cerebral Ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ping-Chang Kuo Research Topics

Disease

7	Ischemic Stroke 01/2023 - 01/2016
4	Brain Injuries (Brain Injury) 01/2023 - 12/2017
4	Neuroinflammatory Diseases 01/2022 - 03/2018
4	Multiple Sclerosis 01/2021 - 03/2018
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2021 - 10/2016
3	Inflammation (Inflammations) 04/2020 - 01/2017
3	Brain Ischemia (Cerebral Ischemia) 12/2017 - 01/2016
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 01/2016
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 04/2020
1	Infarction (Infarctions) 01/2022
1	Stroke (Strokes) 01/2021
1	Gliosis 03/2018
1	Cognitive Dysfunction 03/2018
1	Out-of-Hospital Cardiac Arrest 12/2017
1	Ischemia 12/2017
1	Brain Infarction 12/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Relapsing-Remitting Multiple Sclerosis 01/2016
1	Reperfusion Injury 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016
1	Parkinson Disease (Parkinson's Disease) 01/2016
1	Starvation 01/2015
1	Body Weight (Weight, Body) 01/2015
1	Breast Neoplasms (Breast Cancer) 12/2009
1	Neoplasms (Cancer) 12/2009
1	Retinal Detachment (Retinal Detachments) 10/2008
1	Necrosis 02/2008
1	Leukemia 02/2008
1	Burns 12/2007
1	Corneal Neovascularization 12/2007

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 01/2022 - 01/2016
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2023 - 01/2016
3	InterferonsIBA 01/2023 - 01/2016
3	Heme Oxygenase-1IBA 01/2022 - 10/2008
3	Therapeutic UsesIBA 05/2021 - 01/2016
2	4-ethylguaiacolIBA 01/2022 - 05/2021
2	itaconic acidIBA 01/2021 - 04/2020
2	dimethyl itaconateIBA 01/2021 - 04/2020
2	1,2-dithiol-3-thioneIBA 05/2017 - 10/2016
1	Interferon-betaIBA 01/2023
1	PhenolsIBA 05/2021
1	Evans Blue (Blue, Evans)FDA Link 01/2021
1	AntioxidantsIBA 03/2018
1	Dimethyl FumarateIBA 03/2018
1	Lamotrigine (Lamictal)FDA LinkGeneric 12/2017
1	Drug CombinationsIBA 12/2017
1	Lovastatin (Mevacor)FDA LinkGeneric 12/2017
1	Minocycline (Cyclops)FDA LinkGeneric 12/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2017
1	Interleukin-27 (Interleukin 27)IBA 01/2017
1	ProstaglandinsIBA 01/2017
1	Dinoprostone (PGE2)FDA Link 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2017
1	Glutathione (Reduced Glutathione)IBA 01/2016
1	ElementsIBA 01/2015
1	LipidsIBA 01/2015
1	Estrogen ReceptorsIBA 12/2009
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2009
1	Propidium (Propidium Iodide)IBA 02/2008
1	pigment epithelium-derived factorIBA 02/2008
1	Cytochromes c (Cytochrome c)IBA 02/2008
1	PPAR gammaIBA 02/2008
1	Caspase 9IBA 02/2008
1	AngiostatinsIBA 12/2007
1	AlkaliesIBA 12/2007

Therapy/Procedure

3	Therapeutics 03/2018 - 12/2009
1	Slit Lamp 12/2007